New treatments for difficult-to-treat wound infections caused by bacteria.
Engineered Polymer Nanoemulsions for Treatment of Wound Biofilm Infections
This study is exploring new ways to treat stubborn infections that don't respond to regular antibiotics, using special tiny particles in wound dressings that can target and kill the harmful bacteria while keeping healthy cells safe, which could really help people with chronic wounds or tough infections.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Massachusetts Amherst NIH-funded |
| Lab location | 1 site (Hadley, United States) |
| Project ID | NIH-10872284 on NIH RePORTER |
What this research studies
This research focuses on developing innovative therapies to combat multidrug-resistant biofilm infections, which are notoriously hard to treat with standard antibiotics. The approach involves creating engineered polymer nanoemulsions that can effectively kill bacteria within biofilms while minimizing harm to surrounding healthy cells. By incorporating these nanoemulsions into hydrogel wound dressings, the research aims to provide a controlled release of antimicrobial agents directly to the infection site. Patients with chronic wounds or infections that have not responded to traditional treatments may benefit from this advanced therapeutic strategy.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with chronic wounds or infections caused by multidrug-resistant bacteria.
Not a fit: Patients with acute infections that respond well to standard antibiotic treatments may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for patients suffering from stubborn wound infections, improving healing outcomes.
How similar studies have performed: Other research has shown promise in using nanomedicine approaches for treating bacterial infections, indicating potential for success in this novel application.
Where this research is happening
Hadley, United States
- University of Massachusetts Amherst — Hadley, United States (Active)
Researchers
- Principal investigator: Rotello, Vincent M. — University of Massachusetts Amherst
- Study coordinator: Rotello, Vincent M.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.